Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Eiko LifeSciences signs MoU with Vivacious Pharmatex
ELL to make strategic investment in VPPL by way of acquiring 5 per cent equity stake in VPPL
An AI tool to catalyse Mission $100 billion nutraceutical India by 2030
Expert Speak | Amit Srivastava, Chief Catalyst, NutrifyToday.com
SCHOTT launches production of amber pharma glass in India
EUR 75 million (approx. Rs 660 Cr) invested across three years to double SCHOTT’s pharma tubing capacities in the region
Unichem gets USFDA approval for ranolazine ER tablets, 500 mg and 1000 mg
Ranolazine ER tablets are indicated for the treatment of chronic angina
Jubilant gets additional loan from Canada Govt for expansion of CMO Montreal facility
Government of Canada to provide, through its Strategic Innovation Fund (SIF) program, a partially repayable loan of CAD 23.8…
US FDA accepts Glenmark’s IND application for GRC 54276 to proceed with Phase 1/2 clinical study for…
GRC54276 is an orally available, small molecule hematopoietic progenitor kinase 1 (HPK1) inhibitor developed by Glenmark
Eris Lifesciences acquires nine dermatology brands from Dr Reddy’s for Rs 2,750 mn
Eris entered the dermatology segment through the acquisition of Oaknet Healthcare for Rs 6,500 million in May 2022 and…
Körber’s Werum PAS-X MES gets Asia Bioprocessing Excellence Award in ‘software’ category
The Asia Pacific Bioprocessing Excellence Award honors experts, organisations and technologies that offer excellence enabling…
Blockbuster Enhertu may get tumor agnostic label, targeting any HER2-expressing cancer: GlobalData
GlobalData’s consensus forecast projects global sales for Enhertu to reach $9.9 billion by 2028
MSN Group launches Fesobig to treat urinary incontinence and overactive bladder
It is first-line therapy recommended by various international treatment guideline for overactive bladder (OAB)